Voyager Therapeutics, Inc. 8-K

What Happened
Voyager Therapeutics, Inc. (VYGR) filed a Form 8-K on January 8, 2026 (Item 7.01) to disclose that it has posted its current corporate investor presentation to the "Investors" section of its website (https://www.voyagertherapeutics.com/) and plans to distribute a letter summarizing parts of that presentation to specified stockholders. The presentation and the stockholder letter are furnished as Exhibits 99.1 and 99.2 to the Form 8-K. The company clarified that website content is not incorporated by reference into the filing.

Key Details

• Filing date: January 8, 2026 (Form 8-K, Item 7.01 — Regulation FD Disclosure).
• Materials: Corporate investor presentation (Exhibit 99.1) and letter to stockholders (Exhibit 99.2) furnished with the filing.
• Location: Presentation posted to Voyager’s Investors webpage: https://www.voyagertherapeutics.com/.
• Note: Company emphasized website content is not incorporated by reference into the 8-K.

Why It Matters
This is a routine Regulation FD disclosure informing the market that Voyager is sharing an updated investor presentation and a summary letter with select stockholders. Investors should review the furnished presentation and letter (Exhibits 99.1 and 99.2) for any updates on the company’s business, programs, or strategy; the 8-K itself does not change prior financial filings.